Tilray Brands (TLRY) Operating Income Growth (5y) (2025 - 2026)

Tilray Brands (TLRY) Operating Income Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn
3 Zoetis 32.71 Bn 30.77 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.62 Bn 23.56 Bn 4.39 Bn
5 United Therapeutics 23.18 Bn 21.03 Bn 648.10 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn -
7 Viatris 20.28 Bn 18.48 Bn 1.16 Bn
8 Neurocrine Biosciences 17.80 Bn 16.48 Bn 800.70 Mn
9 Elanco Animal Health 12.67 Bn 12.24 Bn 785.00 Mn
10 Tilray Brands 445.07 Mn 384.87 Mn 54.95 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 -1.87%
Nov 30, 2025 3.01%
Aug 31, 2025 17.58%
May 31, 2025 -205.19%